CS202096B2 - Method of preparing analogues of somatostatine - Google Patents

Method of preparing analogues of somatostatine Download PDF

Info

Publication number
CS202096B2
CS202096B2 CS782580A CS258078A CS202096B2 CS 202096 B2 CS202096 B2 CS 202096B2 CS 782580 A CS782580 A CS 782580A CS 258078 A CS258078 A CS 258078A CS 202096 B2 CS202096 B2 CS 202096B2
Authority
CS
Czechoslovakia
Prior art keywords
group
phe
acid
groups
lys
Prior art date
Application number
CS782580A
Other languages
Czech (cs)
English (en)
Inventor
James E Shields
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Priority to CS796664A priority Critical patent/CS212246B2/cs
Publication of CS202096B2 publication Critical patent/CS202096B2/cs

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/655—Somatostatins
    • C07K14/6555—Somatostatins at least 1 amino acid in D-form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/16—Somatostatin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/28—Bound to a nonpeptide drug, nonpeptide label, nonpeptide carrier, or a nonpeptide resin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Endocrinology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CS782580A 1977-04-21 1978-04-21 Method of preparing analogues of somatostatine CS202096B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS796664A CS212246B2 (cs) 1977-04-21 1979-10-02 Způsob přípravy tetradekapeptidu

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/789,472 US4100117A (en) 1977-04-21 1977-04-21 Somatostatin analogs and intermediates thereto

Publications (1)

Publication Number Publication Date
CS202096B2 true CS202096B2 (en) 1980-12-31

Family

ID=25147748

Family Applications (1)

Application Number Title Priority Date Filing Date
CS782580A CS202096B2 (en) 1977-04-21 1978-04-21 Method of preparing analogues of somatostatine

Country Status (31)

Country Link
US (1) US4100117A (fr)
JP (1) JPS53132588A (fr)
AR (1) AR221699A1 (fr)
AT (1) AT361142B (fr)
AU (1) AU519275B2 (fr)
BE (1) BE866117A (fr)
BG (1) BG28703A3 (fr)
CA (2) CA1102315A (fr)
CH (1) CH634039A5 (fr)
CS (1) CS202096B2 (fr)
DD (1) DD135900A5 (fr)
DE (1) DE2816854A1 (fr)
DK (1) DK174278A (fr)
ES (2) ES469005A1 (fr)
FI (1) FI64576C (fr)
FR (1) FR2387941A1 (fr)
GB (1) GB1596328A (fr)
GR (1) GR68945B (fr)
HU (1) HU177435B (fr)
IE (1) IE46868B1 (fr)
IL (1) IL54533A (fr)
IT (1) IT1094462B (fr)
NL (1) NL7804218A (fr)
NZ (1) NZ187009A (fr)
PL (2) PL115827B1 (fr)
PT (1) PT67913B (fr)
RO (2) RO81079A (fr)
SE (1) SE7804397L (fr)
SU (2) SU730295A3 (fr)
YU (1) YU91578A (fr)
ZA (1) ZA782247B (fr)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4202802A (en) * 1978-10-02 1980-05-13 Eli Lilly And Company Peptides related to somatostatin
US4199501A (en) * 1978-11-20 1980-04-22 Eli Lilly And Company Peptides related to somatostatin
US4199500A (en) * 1978-11-20 1980-04-22 Eli Lilly And Company Peptides related to somatostatin
US4428942A (en) 1982-05-17 1984-01-31 The Salk Institute For Biological Studies Analogs of somatostatin
GB8423431D0 (en) * 1984-09-17 1984-10-24 Sandoz Ltd Organic compounds
SE8702550D0 (sv) * 1987-06-18 1987-06-18 Anders Grubb Cysteinproteashemmare
NZ240214A (en) 1990-10-16 1993-02-25 Takeda Chemical Industries Ltd Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
ES2110573T3 (es) 1992-08-07 1998-02-16 Takeda Chemical Industries Ltd Produccion de microcapsulas de farmacos solubles en agua.
US5594091A (en) * 1994-02-21 1997-01-14 Takeda Chemical Industries, Ltd. Matrix for sustained-release preparation
US6117455A (en) 1994-09-30 2000-09-12 Takeda Chemical Industries, Ltd. Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
CA2192782C (fr) 1995-12-15 2008-10-14 Nobuyuki Takechi Production de microsphere
EP0813887A3 (fr) * 1996-06-20 1999-11-03 Hisamitsu Pharmaceutical Co. Inc. Appareil d'ionophorèse
US6309633B1 (en) 1999-06-19 2001-10-30 Nobex Corporation Amphiphilic drug-oligomer conjugates with hydroyzable lipophile components and methods for making and using the same
US7169889B1 (en) 1999-06-19 2007-01-30 Biocon Limited Insulin prodrugs hydrolyzable in vivo to yield peglylated insulin
US7090869B2 (en) 2000-12-01 2006-08-15 Takeda Pharmaceutical Company Limited Method for producing preparation containing bioactive substance
US7060675B2 (en) * 2001-02-15 2006-06-13 Nobex Corporation Methods of treating diabetes mellitus
US6867183B2 (en) * 2001-02-15 2005-03-15 Nobex Corporation Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US6835802B2 (en) * 2001-06-04 2004-12-28 Nobex Corporation Methods of synthesizing substantially monodispersed mixtures of polymers having polyethylene glycol moieties
US6828305B2 (en) * 2001-06-04 2004-12-07 Nobex Corporation Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6828297B2 (en) 2001-06-04 2004-12-07 Nobex Corporation Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6858580B2 (en) * 2001-06-04 2005-02-22 Nobex Corporation Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US7713932B2 (en) * 2001-06-04 2010-05-11 Biocon Limited Calcitonin drug-oligomer conjugates, and uses thereof
US6713452B2 (en) * 2001-06-04 2004-03-30 Nobex Corporation Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same
US6913903B2 (en) * 2001-09-07 2005-07-05 Nobex Corporation Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7166571B2 (en) * 2001-09-07 2007-01-23 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7312192B2 (en) * 2001-09-07 2007-12-25 Biocon Limited Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same
US7196059B2 (en) 2001-09-07 2007-03-27 Biocon Limited Pharmaceutical compositions of insulin drug-oligomer conjugates and methods of treating diseases therewith
US7601688B2 (en) * 2002-06-13 2009-10-13 Biocon Limited Methods of reducing hypoglycemic episodes in the treatment of diabetes mellitus
PL1773878T3 (pl) 2004-07-19 2015-07-31 Biocon Ltd Koniugaty insulina-oligomer, ich formulacje i zastosowania
US9241908B2 (en) 2007-10-16 2016-01-26 Biocon Limited Orally administrable solid pharmaceutical composition and a process thereof
JP6224586B2 (ja) 2012-07-10 2017-11-01 武田薬品工業株式会社 注射用製剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2608336A1 (de) * 1975-03-11 1976-09-30 Sandoz Ag Neue organische verbindungen, ihre herstellung und verwendung
US4372884A (en) * 1975-08-06 1983-02-08 The Salk Institute For Biological Studies Pharmaceutically active peptides

Also Published As

Publication number Publication date
HU177435B (en) 1981-10-28
SU904519A3 (ru) 1982-02-07
ES476901A1 (es) 1979-10-16
RO81079A (fr) 1983-06-01
FI781184A (fi) 1978-10-22
FR2387941A1 (fr) 1978-11-17
PL114533B1 (en) 1981-02-28
PT67913B (en) 1979-11-14
BE866117A (fr) 1978-10-19
IE780765L (en) 1978-10-21
FR2387941B1 (fr) 1983-06-10
SU730295A3 (ru) 1980-04-25
IE46868B1 (en) 1983-10-19
CA1113928A (fr) 1981-12-08
DD135900A5 (de) 1979-06-06
NL7804218A (nl) 1978-10-24
BG28703A3 (en) 1980-06-16
AR221699A1 (es) 1981-03-13
YU91578A (en) 1983-01-21
AT361142B (de) 1981-02-25
CH634039A5 (de) 1983-01-14
DE2816854A1 (de) 1978-11-02
GB1596328A (en) 1981-08-26
CA1102315A (fr) 1981-06-02
PL206280A1 (fr) 1980-01-02
IT1094462B (it) 1985-08-02
PL115827B1 (en) 1981-05-30
JPS53132588A (en) 1978-11-18
FI64576B (fi) 1983-08-31
US4100117A (en) 1978-07-11
AU3525378A (en) 1979-10-25
RO76054A (fr) 1981-08-17
GR68945B (fr) 1982-03-29
ES469005A1 (es) 1979-09-01
DK174278A (da) 1978-10-22
IL54533A (en) 1982-11-30
IT7822552A0 (it) 1978-04-20
ZA782247B (en) 1979-12-27
RO81079B (ro) 1983-05-30
SE7804397L (sv) 1978-10-22
NZ187009A (en) 1981-04-24
AU519275B2 (en) 1981-11-19
IL54533A0 (en) 1978-07-31
ATA282878A (de) 1980-07-15
PT67913A (en) 1978-05-01
FI64576C (fi) 1983-12-12

Similar Documents

Publication Publication Date Title
CS202096B2 (en) Method of preparing analogues of somatostatine
AU2022200089B2 (en) Cyclic peptide tyrosine tyrosine compounds as modulators of Neuropeptide Y receptors
AU662731B2 (en) Growth hormone releasing factor analogs
EP0395417B1 (fr) Analogues linéaires de somatostatine
US4087390A (en) Somatostatin analogs and intermediates thereto
US4093574A (en) Somatostatin analogs and intermediates thereto
RU2627184C2 (ru) Гликозилированные полипептиды и лекарственные композиции, содержащие данные полипептиды
JP3983806B2 (ja) ソマトスタチンの環状ペプチド類似体
EA008837B1 (ru) Аналоги глюкагоноподобного пептида и их применение
CZ281507B6 (cs) Syntetické peptidy, biologický aktivní fragment a jejich netoxické soli
PT88914B (pt) Processo para a preparacao de polipetidos e de composicoes farmaceuticas que os contem
PL169498B1 (pl) Sposób wytwarzania nowych zwiazków polipeptydowych PL PL
NZ230549A (en) Linear and cyclic growth hormone releasing factor analogues
JP2013542211A (ja) グルコース依存性インスリン分泌促進ペプチド類似体
US4490364A (en) CCK Agonists II
EP0215171A2 (fr) Peptides
CZ158895A3 (en) Insulin analog, process of its preparation and pharmaceutical composition containing thereof
JP2001505580A (ja) ソマトスタチン類似体
EP0300737B1 (fr) Dérivés de gènes peptides de calcitonine apparentés
JPH01129000A (ja) 環式ペプチド
EP0298732A2 (fr) Analogues thérapeutiques de somatostatine
Boissonnas et al. Chemistry of the neurohypophysial hormones
EP0386044B1 (fr) Peptides hypoglycemiques
AU596665B2 (en) Novel hepta and/or octa-peptides
Yabe et al. Synthesis and biological activity of somatostatin analogues modified at the tryptophan residue